Michael Mason - Net Worth and Insider Trading
Michael Mason Net Worth
The estimated net worth of Michael Mason is at least $407,587 dollars as of 2024-10-05. Michael Mason is the EVP, CFO & Treasurer of Karyopharm Therapeutics Inc and owns about 391,054 shares of Karyopharm Therapeutics Inc (KPTI) stock worth over $347,021. Michael Mason is also the VP, Finance and Treasurer of Alnylam Pharmaceuticals Inc and owns about 226 shares of Alnylam Pharmaceuticals Inc (ALNY) stock worth over $60,566. Details can be seen in Michael Mason's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Michael Mason has not made any transactions after 2024-09-04 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Michael Mason
Michael Mason Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Michael Mason owns 2 companies in total, including Karyopharm Therapeutics Inc (KPTI) , and Alnylam Pharmaceuticals Inc (ALNY) .
Click here to see the complete history of Michael Mason’s form 4 insider trades.
Insider Ownership Summary of Michael Mason
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| KPTI | Karyopharm Therapeutics Inc | 2024-09-04 | EVP & CFO & Treasurer |
| ALNY | Alnylam Pharmaceuticals Inc | 2018-01-04 | VP & Finance and Treasurer |
Michael Mason Latest Holdings Summary
Michael Mason currently owns a total of 2 stocks. Among these stocks, Michael Mason owns 391,054 shares of Karyopharm Therapeutics Inc (KPTI) as of September 4, 2024, with a value of $347,021 and a weighting of 85.14%. Michael Mason also owns 226 shares of Alnylam Pharmaceuticals Inc (ALNY) as of January 4, 2018, with a value of $60,566 and a weighting of 14.86%.
Latest Holdings of Michael Mason
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| KPTI | Karyopharm Therapeutics Inc | 2024-09-04 | 391,054 | 0.89 | 347,021 |
| ALNY | Alnylam Pharmaceuticals Inc | 2018-01-04 | 226 | 267.99 | 60,566 |
Holding Weightings of Michael Mason
Michael Mason Form 4 Trading Tracker
According to the SEC Form 4 filings, Michael Mason has made a total of 13 transactions in Karyopharm Therapeutics Inc (KPTI) over the past 5 years, including 0 buys and 13 sells. The most-recent trade in Karyopharm Therapeutics Inc is the sale of 7,050 shares on September 4, 2024, which brought Michael Mason around $5,076.
According to the SEC Form 4 filings, Michael Mason has made a total of 0 transactions in Alnylam Pharmaceuticals Inc (ALNY) over the past 5 years. The most-recent trade in Alnylam Pharmaceuticals Inc is the sale of 36,745 shares on January 4, 2018, which brought Michael Mason around $5 Million.
Insider Trading History of Michael Mason
- 1
Michael Mason Trading Performance
Michael Mason Ownership Network
Michael Mason Owned Company Details
What does Karyopharm Therapeutics Inc do?
Who are the key executives at Karyopharm Therapeutics Inc?
Michael Mason is the EVP & CFO & Treasurer of Karyopharm Therapeutics Inc. Other key executives at Karyopharm Therapeutics Inc include SVP & General Counsel&Secretary Michael Mano , director & President and CEO Richard A. Paulson , and SVP Sales & Commercial Ops Sohanya Roshan Cheng .
Karyopharm Therapeutics Inc (KPTI) Insider Trades Summary
Over the past 18 months, Michael Mason made 7 insider transaction in Karyopharm Therapeutics Inc (KPTI) with a net sale of 55,845. Other recent insider transactions involving Karyopharm Therapeutics Inc (KPTI) include a net sale of 162,205 shares made by Richard A. Paulson , a net sale of 41,559 shares made by Sohanya Roshan Cheng , and a net sale of 34,041 shares made by Stuart Poulton .
In summary, during the past 3 months, insiders sold 26,535 shares of Karyopharm Therapeutics Inc (KPTI) in total and bought 0 shares, with a net sale of 26,535 shares. During the past 18 months, 2,081,475 shares of Karyopharm Therapeutics Inc (KPTI) were sold and 41,140 shares were bought by its insiders, resulting in a net sale of 2,040,335 shares.
Karyopharm Therapeutics Inc (KPTI)'s detailed insider trading history can be found in Insider Trading Tracker table.
Karyopharm Therapeutics Inc Insider Transactions
Michael Mason Mailing Address
Above is the net worth, insider trading, and ownership report for Michael Mason. You might contact Michael Mason via mailing address: 300 3rd Street, Cambridge Ma 02142.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
